HM Government has published its Future Partnership Paper - "Collaboration on science and innovation.
The Executive summary comments that:
Industry proposals to help the UK’s life sciences sector become an international benchmark for success will be unveiled by Professor Sir John Bell during a speech at the University of Birmingham’s Institute of Translational Medicine later today (30 August 2017).
Attended by Business Secretary Greg Clark and Health Secretary Jeremy Hunt, Sir John Bell will outline the industry’s vision for how government can work alongside the sector to boost businesses large and small across the £64 billion life sciences sector.
Singapore is the de-facto launch-pad into ASEAN (Association of South East Asian Nations), a collection of nation states home to over 600 million consumers with increasing spending power. It's for this reason that Enterprise Nation's third trade mission of 2017 is to the small state of Singapore that offers huge potential.
Chief Executive Officer Science Parks
University of Leicester
The most innovative UK companies are invited to apply for one of the country’s most prestigious business awards and get global recognition.
The Queen’s Awards for Enterprise recognise the contributions and outstanding achievement of UK businesses in the following categories:
- international trade
- sustainable development
promoting opportunity through social mobility
The House of Lords Science and Technology Committee has launched an inquiry into Life Sciences and the Industrial Strategy. Please follow the link below to access the Call for Evidence which outlines the scope of the inquiry and invites written submissions. Please note that the Committee is interested in hearing views from both inside and outside of the life sciences sector.
The deadline for written submissions is Friday 15 September 2017.
Universities and Science Minister Jo Johnson spoke at the inaugural event for Instruct, the structural biology ERIC.
Jo Johnson MP said:
Professor Sir Mark Walport, Chief Executive Designate of UK Research and Innovation, has given a speech outlining the vision, objectives and next steps in development for the organisation.
Be the best research and innovation agency
The board of directors of the Medicines Discovery Catapult (MDC) and the Precision Medicine Catapult (PMC) have proposed the transfer of some aspects of the scientific mission of PMC to the MDC.
MDC will now focus on: medicines; diagnostics; biomarkers; early-stage clinical trial support. They believe the move reflects the change in precision medicine becoming mainstream and integrated within modern drug discovery, and will drive efficiencies and serve as a community one-stop shop for all drug-based approaches. The PMC will close as an entity in its own right.